Richard C. Young & Co’s Astera Labs ALAB Stock Holding History

Richard C. Young & Co’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-556	Closed	-$269K	–	101
2026 Q2	$269K	Buy	+556	New	+$148K	0.02%	93

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $200B AUM 30.19% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Richard C. Young & Co's ALAB Position: Q3 2026 in Review

Richard C. Young & Co sold out of Astera Labs (ALAB) in Q3 2026, closing a stake of 556 shares — an estimated $269K sold.

Richard C. Young & Co first reported a position in ALAB in Q2 2026 and held it in 1 quarter. The position peaked at $269K in Q2 2026. 568 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

Richard C. Young & Co reported no remaining Astera Labs position as of Q3 2026 after selling out during the quarter.
Richard C. Young & Co sold 556 Astera Labs shares in Q3 2026, an estimated $269K.
Richard C. Young & Co first reported a position in Astera Labs in Q2 2026 and held it in 1 quarter.
Richard C. Young & Co's Astera Labs position peaked at $269K in Q2 2026.
568 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Richard C. Young & Co's 13F filing for Q3 2026, filed 4 Nov 2026.